tenofovir alafenamide 15 MG
RxNorm concept 2584353, clinical drug component (scdc).
- RxCUI
- 2584353
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2584353 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- bictegravir 30 MG / emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet (SCD, constitutes)
- bictegravir 30 MG / emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet [Biktarvy] (SBD, constitutes)
- emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet (SCD, constitutes)
- emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet [Descovy] (SBD, constitutes)
- tenofovir alafenamide (IN, has ingredient)
- bictegravir 30 MG / emtricitabine 120 MG / tenofovir alafenamide 15 MG [Biktarvy] (SBDC, has tradename)
- emtricitabine 120 MG / tenofovir alafenamide 15 MG [Descovy] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2584353 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2584353 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2584353. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.